GenTraceDx for Patients

GenTraceDx is a precision oncology platform designed to help you and your care team better understand your cancer, with insights that continue to update over time. 

Participation in GenTraceDx is available through your oncologist as part of a national clinical pilot.

Download clinical pilot information for your oncologist (PDF) →

Why This Matters for You

Cancer research is advancing rapidly. New treatments and clinical trials are being developed all the time.

However, most testing today:

  • Looks at only a limited portion of your cancer’s biology
  • Provides a one-time result that does not update as new information becomes available
  • Relies on limited technology to identify potential treatment options

This means important treatment opportunities may not be identified, especially as new options emerge over time.

GenTraceDx is different

GenTraceDx is designed to:

  • Identify potential treatment opportunities based on your cancer’s unique profile
  • Include RNA insights to provide deeper insight into your cancer
  • Continuously update your results as new therapies and trials become available
  • Help your care team stay aligned with the latest medical knowledge

How GenTraceDx Works

Step 1

Start by speaking with your oncologist

Download information about the GenTraceDx clinical pilot (PDF) and discuss it with your oncologist.

Step 1

Step 2

Comprehensive testing is performed

Your tumor and normal samples are analyzed using advanced genomic and RNA sequencing.

Step 2

Step 3

You receive an initial report

Your oncologist receives detailed insights into potential treatment options.

Step 3

Step 4

Your results continue to evolve

As new therapies and research emerge, your results are updated over time.

Step 4

Step 5

Ongoing access through a secure portal

You and your oncologist can view updates and insights throughout your care.

Step 5

GenTraceDx National Pilot (Canada)

GenTraceDx is being introduced through a 500-patient national clinical pilot across Canada.

The goal of the pilot:
  • Evaluate how this approach works in real-world clinical care
  • Expand access to advanced genomic and RNA-based analysis
  • Help connect patients to relevant therapies and trials

How to Participate

GenTraceDx is available through participating oncologists and cancer centres.

To be considered:
  • Speak with your oncologist, ask whether they are participating in the GenTraceDx pilot
  • If your oncologist is not yet enrolled, provide them with information about the GenTraceDx clinical pilot
  • Once enrolled, your oncologist can submit your case, and eligibility is determined based on program criteria
Download clinical pilot information for your oncologist (PDF) →
PATIENT TOOLKIT

Share with Your Care Team

If you are interested in GenTraceDx, you can download clinical pilot information to share with your oncologist. This includes:
  • Overview of the platform
  • Clinical workflow
  • Pilot details
  • Enrollment information
Download clinical pilot information for your oncologist (PDF) →
PATIENT PORTAL

Patient Access

Patients enrolled in the program have access to a secure portal where they can:
  • View their genomic report
  • See updated insights over time
  • Access educational information

What to Expect

  • GenTraceDx is designed to support your care team by providing additional insights.
  • It does not replace your oncologist
  • It does not guarantee specific outcomes
  • It is part of a broader clinical decision-making process

All treatment decisions remain with your oncologist.

Questions?

If you have questions about the program:
Scroll to Top